Fundamental Analysis of Nextgen Healthcare Inc - Growth / Value Index
NXGN - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.322
Tsr Value Index - Poor Score of 20.31
Book Value in last 3 years is trending down
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | -258.03 | -604.41 | -160.26 % | |
| Price to Book | 3.83 | 4.01 | 4.43 % | 3.83 |
| Price to Sales | 2.31 | 2.46 | -9.75 % | |
| Enterprise Value to EBITDA Multiple | 134.87 | -459.40 | -1533.09 % |
NXGN - Profitability Highlights
Profitability Analysis
Piotroski F Score - Stable Value of 4.0
Reasonable Dividend Yield of 4.97 %
Tsr Profitability Index - Very Poor Score of 5.00
In the last three years, the company has given poor Net Margin
In the last three years, the company has given poor Returns on Equity
In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | -1.48 | -0.663 | -273.30 % | 1.19 |
| Return On Asset | -0.754 | -0.296 | -214.89 % | 0.589 |
| Net Profit Margin | -0.894 | -0.406 | -249.76 % | 2.87 |
| Operating Profit Margin | -0.177 | -0.305 | -127.34 % | 4.57 |
| EBITDA Margin | 1.90 | -0.592 | -107.20 % | 4.57 |
Highlights
| Market Cap | 1606.30 M |
| Enterprise Value | 1778.25 M |
| Price/Book TTM | 3.83 |
| Outstanding Share | 67096.90 K |
| Float/ Outstanding Share | 81.51% |
| Dividend Yield | 4.97 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 4.00 |
| Altman Z Score | 3.00 |
| Sloan Ratio | 0.190 |
| Peter Lynch Fair Value | 0 |
NXGN - Growth Highlights
Growth Analysis
Annual sales of the company is increased for three years in a row
Tsr Growth Index - Very Poor Score of 15.14
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 695052 K | 9.53 % | 1.00 % |
| Gross Profit | 322490 K | 3.39 % | 2.26 % |
| EBITDA | 13185.00 K | 107.89 % | 11.14 % |
| Net Profit | -6214.00 K | 264.03 % | 17.88 % |
| EPS | -0.093 | 265.95 % | NA |
NXGN - Stability Highlights
Stability Analysis
Company financial liquidity has improved
Tsr Stability Index - Poor Score of 28.12
Interest Coverage of -5.63
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.676 | 3435.35 % | 0.640 |
| Cash Ratio | 1.20 | 263.67 % | |
| Quick Ratio | 1.99 | 99.64 % | 2.33 |
| Shareholders Equity | 44.69 | -33.70 % | |
| Debt to EBITDA | -70.01 | -42519.60 % |
Historical Valuation Ratios of Nextgen Healthcare Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Nextgen Healthcare Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Nextgen Healthcare Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Nextgen Healthcare Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)